{
  "ticker": "LLY",
  "target_date": "2025-07-18",
  "actual_date": "2025-07-18",
  "collected_at": "2025-12-08T12:02:00.179231",
  "price": {
    "open": 761.07,
    "high": 773.12,
    "low": 757.72,
    "close": 768.8895263671875,
    "volume": 3357700,
    "change_1d_pct": 1.34,
    "change_7d_pct": -1.93,
    "change_30d_pct": 0.77
  },
  "technicals": {
    "rsi_14": 48.57,
    "sma_20": 777.39,
    "sma_50": 763.79,
    "macd": -0.067,
    "macd_signal": 1.862,
    "macd_histogram": -1.93,
    "bb_upper": 798.56,
    "bb_lower": 756.23,
    "price_vs_sma20_pct": -1.09,
    "price_vs_sma50_pct": 0.67,
    "volume_ratio": 1.04
  },
  "fundamentals": {
    "market_cap": 893193682944,
    "pe_ratio": 48.817245,
    "forward_pe": 43.96999,
    "price_to_book": 37.513554,
    "price_to_sales": 15.03192,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.4,
    "pct_from_52w_low": 59.73
  },
  "macro": {
    "spy": {
      "price": 625.84,
      "change_1d_pct": -0.07,
      "change_7d_pct": 0.28
    },
    "vix": {
      "level": 16.41,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.43
    },
    "dollar_index": {
      "level": 98.48
    },
    "gold": {
      "price": 3353.0
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "J.P. Morgan Sees Strong Q2 for Eli Lilly, Maintains Overweight Rating",
      "source": "Yahoo",
      "datetime": 1752864352,
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set to report second-quarter results on August 7, and J.P. Morgan\u2019s Chris Schott believes the stage is set for another strong showing. In a recent note, Schott outlined what he ca",
      "url": "https://finnhub.io/api/news?id=a51afc7c8d667237d782510e2f42747cf36d8e0ad7c3552af5d9d6162c7521b1"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1752856260,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=10ef1dd32da56b51c9e208aa46d5076395ec37475bc144374bd2c2d563b6c483"
    },
    {
      "headline": "Can Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?",
      "source": "Yahoo",
      "datetime": 1752845940,
      "summary": "Wegovy and Ozempic drive 66% of NVO's Q1 revenues - investors eye Q2 sales ahead of results on Aug. 6.",
      "url": "https://finnhub.io/api/news?id=9fa67786cdd95cd2bca8fc1544e12476db4968112863bd4c9e52004d2827d1fb"
    },
    {
      "headline": "Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet",
      "source": "Yahoo",
      "datetime": 1752845403,
      "summary": "The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=19dd27e8f56655e550872ef20d07ba1d8749807cee44bb258c248a82e22d8612"
    },
    {
      "headline": "Can Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs?",
      "source": "Yahoo",
      "datetime": 1752828420,
      "summary": "President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.  Lilly's margins could be negatively affected if the company absorbs the higher costs.  The active ingredients of roughly 80% of prescription drugs sold in the U.S. are made in other countries.",
      "url": "https://finnhub.io/api/news?id=41188ca1eb21588a7d6a4618c56aa39295dad097da2dabfc5ebd936d9befee48"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199300.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199159.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198988.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198711.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198504.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}